Lavan Khandan, PhD
Dr. Khandan joined inThought Research in 2019. He has held previous positions as a Fellow at a life science consulting firm and as a Scientist at Editas Medicine. In these roles, Dr. Khandan built expertise in asset scouting, evaluating rare diseases and therapeutic areas, and building market access and commercial viability assessments.
Dr. Khandan received his Ph.D. in Molecular, Cellular, and Developmental Biology from the University of Colorado, Boulder. His doctoral research focused on signaling and growth factors governing retinal vascularization. He has extensive experience in CRISPR/Cas9 gene editing, stem cell differentiation, and cell therapies. Dr. Khandan received his A.B. in Chemistry from Dartmouth College.